Bob Martin Permethrin 1% w/w Flea Shampoo for Dogs

Summary of Product characteristics

                                Revised: July 2012
AN: 00196/2012 & 00198/2012
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF VETERINARY MEDICINAL PRODUCT
Bob Martin Permethrin 1% w/w Flea Shampoo for Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE(S)
% W/W
Permethrin (Technical)
1.000
Cis:trans 40:60
EXCIPIENTS
Sodium Propyl Hydroxybenzoate………………...0.100
Phenoxyethanol……………………………………0.800
Green colourant…………………………………....0.005
(As Green Colouring W178680 or Percol F731
Contributing :
Patent blue (E131)………………………………....0.0018
Tartrazine (E102)…………………………………..0.0010
Sunset Yellow (E110)……………………………..0.0010)
For a full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Shampoo
Green viscous liquid
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES.
For the control of fleas on dogs.
4.3
CONTRA-INDICATIONS
i)
Do not use on cats
ii)
Do not use on puppies under 12 weeks of age
iii)
Do not use on nursing bitches
Page 1 of 5
Revised: July 2012
AN: 00196/2012 & 00198/2012
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Remove fleas from young puppies and from nursing females by careful
use of a
flea comb.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special Precautions for use in animals.
For external use only
Avoid contact with animal’s eyes
Wash any containers used thoroughly
Fleas from pets often infect animals’ baskets, bedding and regular
resting areas such as carpets and soft furnishings. As part of a flea
control programme these areas should also be treated with a suitable
insecticide and vacuumed regularly.
ii.
Special Precautions to be taken by the person administering the
medicinal product to animals
Avoid prolonged contact with the skin. It is advisable to wear
gloves whilst using this product.
Avoid contact with eyes. In case of accidental eye contact, rinse with
clean, fresh water. If eye irritation persists, seek medical advice.
Treated animal
                                
                                Read the complete document